Dexcom (DXCM) Amortization of Deferred Charges (2016 - 2025)
Historic Amortization of Deferred Charges for Dexcom (DXCM) over the last 12 years, with Q4 2025 value amounting to $1.7 million.
- Dexcom's Amortization of Deferred Charges fell 1052.63% to $1.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $7.3 million, marking a year-over-year decrease of 266.67%. This contributed to the annual value of $7.3 million for FY2025, which is 266.67% down from last year.
- According to the latest figures from Q4 2025, Dexcom's Amortization of Deferred Charges is $1.7 million, which was down 1052.63% from $1.9 million recorded in Q3 2025.
- Over the past 5 years, Dexcom's Amortization of Deferred Charges peaked at $2.2 million during Q3 2023, and registered a low of $1.4 million during Q4 2021.
- In the last 5 years, Dexcom's Amortization of Deferred Charges had a median value of $1.8 million in 2024 and averaged $1.8 million.
- Its Amortization of Deferred Charges has fluctuated over the past 5 years, first tumbled by 2380.95% in 2022, then soared by 4666.67% in 2023.
- Dexcom's Amortization of Deferred Charges (Quarter) stood at $1.4 million in 2021, then grew by 14.29% to $1.6 million in 2022, then increased by 25.0% to $2.0 million in 2023, then fell by 5.0% to $1.9 million in 2024, then dropped by 10.53% to $1.7 million in 2025.
- Its last three reported values are $1.7 million in Q4 2025, $1.9 million for Q3 2025, and $1.8 million during Q2 2025.